martedì 29 ottobre 2013

Edoardo Cignoli : Pfizer's Earnings Decline 19% on Weaker Sales

Pfizer's third-quarter earnings fell 19% as the drug maker's sales weakened across most of its businesses, particularly its primary care segment.



via WSJ.com: US Business http://online.wsj.com/article/SB10001424052702303471004579165240668917018.html?mod=pls_whats_news_us_business_f

Nessun commento:

Posta un commento